OrthoPediatrics NASDAQ: KIDS reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord Genuity Growth Conference.
OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript
OrthoPediatrics NASDAQ: KIDS reported record second-quarter revenue of $70.5 million, up 15% from a year earlier, as strong Trauma & Deformity and specialty bracing performance offset a reported decline in scoliosis revenue. The company also raised its 2026 revenue outlook while maintaining its adjusted EBITDA and free-cash-flow targets.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 72,123 | $1.38M | $1.64M | $262,530.71 | 19.03% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 199,682 | $3.95M | $4.55M | $596,214.23 | 15.09% |
| JM John Malone Amundi | 62,285 | $3.36M | $1.45M | -$1.91M | -56.88% |
Point72 Asset Management LP Point72 Asset Management LP | 23,126 | $400,220.72 | $573,524.8 | $173,304.08 | 43.3% |
| YA Yinka Akinsola Blue Trust Inc. | 5,000 | $213,318.06 | $100,950 | -$112,368.06 | -52.68% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | David R. Bailey CEO | NASDAQ (NMS) Exchange | 68752L100 CUSIP |
| US Country | 602 Employees | - Last Dividend | - Last Split | 12 Oct 2017 IPO Date |
OrthoPediatrics Corp. stands as a pioneering medical device company primarily focused on the design, development, and marketing of anatomically appropriate implants, instruments, and specialty orthopedic braces for children facing orthopedic conditions. With its inception in 2006, the company has carved a niche within the pediatric orthopedic market both in the United States and on an international scale. OrthoPediatrics Corp.’s mission revolves around catering to pediatric orthopedic surgeons and caregivers, providing them with solutions specifically tailored for the unique anatomy of children. The company is headquartered in Warsaw, Indiana, where it continues to innovate and expand its reach to improve orthopedic care for children globally.
OrthoPediatrics Corp. offers an extensive range of products tailored for pediatric trauma and deformity correction, scoliosis procedures for the treatment of spinal deformities, and sports medicine among others. Their product line includes implants such as the PediLoc and PediPlates which are designed for precision and compatibility with children’s anatomy. The company provides solutions for various orthopedic need—ranging from fracture stabilization (cannulated screws, PediFlex nail, PediNail) to complex deformity correction (RESPONSE Spine, The Fassier-Duval Telescopic Intramedullary System) and targeted growth modulation (GIROTM Growth Modulation System). Further, specialized products like the ACL Reconstruction System and the Mitchell Ponseti for clubfoot treatment showcase their dedication to addressing a wide spectrum of pediatric orthopedic challenges.